US EditionTislelizumab/Chemotherapy Earns EU Approval in Nasopharyngeal Carcinoma
Summary by cancernetwork.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
A Genome-Wide Association Study Integrated With Single-Cell and Bulk Profiles Uncovers Susceptibility Genes for Nasopharyngeal Carcinoma Involved in Tumorigenesis Via Regulation of T Cells
Scientists performed in-depth bioinformatic analysis and functional experiments for EOMES, finding that the nasopharyngeal carcinoma-risk alleles of four functional SNPs upregulate EOMES expression by promoting the activity of regulatory elements in T cells. [Genome Biology] Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
